Prestige Consumer Healthcare (PBH) Cost of Revenue (2010 - 2025)

Prestige Consumer Healthcare's Cost of Revenue history runs 16 years deep, the most recent figure standing at $126.1 million for Q4 2025.

• On a quarterly basis, Cost of Revenue fell 1.01% year-over-year to $126.1 million in Q4 2025; TTM through Dec 2025 was $479.6 million, a 5.21% decrease from a year earlier, with the FY2025 full-year figure at $494.4 million, down 1.3% from the prior year.
• Cost of Revenue rose to $126.1 million in Q4 2025 per PBH's latest filing, from $120.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $132.1 million in Q1 2023 and bottomed at $105.3 million in Q1 2021.
• The 5-year median for Cost of Revenue is $123.6 million (2023), against an average of $121.4 million.
• Across the five-year window, Cost of Revenue climbed 20.64% in 2021 and retreated 9.84% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $119.4 million in 2021, then climbed by 4.78% to $125.1 million in 2022, then dropped by 1.86% to $122.8 million in 2023, then climbed by 3.72% to $127.4 million in 2024, then fell by 1.01% to $126.1 million in 2025.
• Per Business Quant, the three latest PBH Cost of Revenue figures stand at $126.1 million (Q4 2025), $120.0 million (Q3 2025), and $109.2 million (Q2 2025).